Publication: Editorial Comments on "The safety, tolerability, and efficacy of once-daily generic memantine hydrochloride produced in Thailand: A multicenter naturalistic study in dementia patients"
dc.contributor.author | Orapitchaya Krairit | en_US |
dc.contributor.author | อรพิชญา ไกรฤกษ์ | en_US |
dc.contributor.other | Mahidol University. Faculty of Medicine Ramathibodi Hospital. Department of Medicine | en_US |
dc.date.accessioned | 2022-09-22T06:56:29Z | |
dc.date.available | 2022-09-22T06:56:29Z | |
dc.date.created | 2022-09-22 | |
dc.date.issued | 2015 | |
dc.description.abstract | Dementia is a syndrome decline in 2 or more cognitive capacities, causing impairment in function. One of the risk factors for dementia is advanced age. Dementia has become increasingly more common in Thai older adults given the sharp rising number of older people in Thailand. Current available pharmacological treatment aims for delaying progression of the syndrome and to treat the symptoms of dementia are Cholinesterase inhibitors and Memantine. Using generic medication will decrease the price of overall pharmacological treatment. | en_US |
dc.identifier.citation | Ramathibodi Medical Journal. Vol. 38, No. 1 (Jan-Mar 2015), 1-2 | en_US |
dc.identifier.issn | 0125-3611 (Print) | |
dc.identifier.issn | 2651-0561 (Online) | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/79616 | |
dc.language.iso | eng | en_US |
dc.rights | Mahidol University | en_US |
dc.rights.holder | Department of Medicine Faculty of Medicine Ramathibodi Hospital Mahidol University | en_US |
dc.subject | The safety tolerability | en_US |
dc.title | Editorial Comments on "The safety, tolerability, and efficacy of once-daily generic memantine hydrochloride produced in Thailand: A multicenter naturalistic study in dementia patients" | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mods.location.url | https://he02.tci-thaijo.org/index.php/ramajournal/article/view/95131/74324 |